Skip to content

Modeling Clinical Outcomes in Gambling Addiction

Modeling Clinical Outcomes in Gambling Addiction

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06981546
Acronym
MOGADOR
Enrollment
268
Registered
2025-05-20
Start date
2025-09-01
Completion date
2030-09-01
Last updated
2025-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gambling Disorder

Keywords

Gambling disorders, Modeling outcomes, Socio-demographic Characteristics, Clinical psychiatric profiles

Brief summary

Gambling disorder (GD) is recognized as an addictive disorder. Financial consequences of GD are often dramatic, inducing professional, familial, legal and medical repercussions and particularly mental health consequences. MOGADOR is a longitudinal, multicentric, prospective, prognostic study, which aims to identify factors predicting the evolution of french patients with GD in care centers particularly involved in the management of GD. The main goal will focus on evolution of DSM-5 (Diagnostic and Statistical Manual of Mental Disorder 5th edition) GD criteria during the first year of follow-up. The prognostic factors will be collected at base-line and they will be considered to influence the long-term prognosis of patients. For patients suffering of GD, our main hypothesis is that initial factors like individual socio-demographic characteristics, clinical psychiatric profiles, addiction comorbidities, and behaviour are associated with the clinical prognosis (total remission of DSM-5 criteria of GD at 12 months). MOGADOR will be the first study, aiming to model prognostic aspects of GB in populations specially monitored for this disorder.

Interventions

None listed

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient, male or female, over 18 years old, consulting in one of the participating centers. * DSM-5 criteria for gambling disorder at inclusion: at least 4 criteria present in the 12 months preceding the study. * First treatment for gambling disorder or no treatment in the last 6 months (initiation or re-initiation of care).

Exclusion criteria

* Unable to be reached by phone. * Unable to use the internet. * Patient under antiparkinsonian treatment of the dopaminergic family. * Being treated with a drug that may trigger/increase symptoms of gambling disorder (e.g. dopamine agonist). * Subject under guardianship.

Design outcomes

Primary

MeasureTime frameDescription
Partial remission of gambling disorder at 12 months (strictly less than 4 DSM-5 criteria)DSM-5 criteria assessment will be conducted at 9 and 12 months after inclusion.Assessment of DSM-5 criteria will be performed by the clinician, and by a previously trained CRA if clinical follow-up is discontinued.
modeling prognostic factorsat inclusion visit.The prognostic factors, studied will be: number of initial DSM-5 criteria, gender, age, marital status, housing, employment status, socioeconomic level, time spent gambling, impulsivity, type of gambling, location of gambling, and also the factor with the strongest association in univariate analysis among the following factors: * Depression (PHQ scale), * Anxiety (GAD scale), * Quality of life (SF-36 scale).

Countries

France

Contacts

Primary ContactVéronique FONTEILLE, MD, PhD
veronique.fonteille@chu-lyon.fr04 72 11 80 64
Backup ContactPauline DROUIN
pauline.drouin@chu-lyon.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026